Search by Drug Name or NDC
NDC 00067-2001-01 Excedrin 250; 250; 65 mg/1; mg/1; mg/1 Details
Excedrin 250; 250; 65 mg/1; mg/1; mg/1
Excedrin is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
NDC | 00067-2001 |
---|---|
Product ID | 0067-2001_a94552c2-4521-4e49-a759-ff664cdb5966 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Excedrin |
Proprietary Name Suffix | Extra Strength Pain Reliever |
Non-Proprietary Name | Acetaminophen, Aspirin (NSAID), and Caffeine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 250; 250; 65 |
Active Ingredient Units | mg/1; mg/1; mg/1 |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part343 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00067-2001-01 (00067200101)
NDC Package Code | 0067-2001-01 |
---|---|
Billing NDC | 00067200101 |
Package | 2 TABLET, FILM COATED in 1 POUCH (0067-2001-01) |
Marketing Start Date | 2021-01-31 |
NDC Exclude Flag | N |
Pricing Information | N/A |